Alkaline xylanase mutant
By modifying xylanase through protein engineering and introducing specific mutation sites, a heat- and alkali-resistant xylanase mutant was prepared. This solved the problem of decreased activity of xylanase under high temperature and alkaline conditions, achieving higher enzyme activity and stability, and making it suitable for pulp bleaching processes in the papermaking industry.
Patent Information
- Application Number
- CN202411153159.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2021-08-06
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2041-08-06
AI Technical Summary
Existing xylanases are difficult to maintain their activity in high-temperature and slightly alkaline environments during pulp bleaching, which affects the bleaching effect.
Xylanase mutants with heat and alkali resistance were prepared by protein engineering. Specifically, specific mutation sites, such as Q24P, S38V/K/W/H/T/I, G40M/R/K/F/H, and D41P, were introduced into the amino acid sequence of wild-type xylanase H1 to improve its stability under high temperature and alkaline conditions.
The mutant exhibits a 12.2%-71.4% increase in relative enzyme activity at 75℃ and a high residual enzyme activity of 61.51-93.29% at pH 9.0-12.0, significantly enhancing the application potential of xylanase in the papermaking industry.
Smart Images

Figure SMS_1
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of gene engineering and protein engineering, and in particular to an alkaline xylanase mutant. Background Art
[0002] The papermaking industry has always been a highly polluting industry. In recent years, as my country has paid more and more attention to environmental protection and strengthened its efforts in pollution control, the requirements for pulping and papermaking processes have become increasingly higher. Both in terms of improving production processes and adding papermaking additives, they are moving towards green and environmental protection. The application of bioenzymes in the pulping and papermaking industry is becoming more and more extensive, and is used in various stages of the process, such as cooking, bleaching, beating, waste paper deinking, and stickies control. Research on the application of bioenzymes in pulping and bleaching has been a hot topic in the application of bioenzymes in papermaking in recent years. Adding bioenzymes during the bleaching process can reduce the amount of chemical bleaching agents, improve the whiteness of pulp after bleaching, reduce the content of ionic waste in bleaching wastewater, and improve the recycling rate of white water. Enzyme preparations commonly used in pulp bleaching include xylanase and laccase.
[0003] Xylanase in a broad sense refers to a complex enzyme system that can degrade a large amount of hemicellulose xylan present in nature, especially in plant fibers, including β-1, 4-endo-xylanase, β-xylosidase, α-L-arabinosidase, etc. Xylanase in a narrow sense mainly refers to β-1,4-endo-xylanase. β-1,4-endo-xylanase mainly acts on the β-1,4-glycosidic bond in the xylan molecule, and degrades xylan into small molecular oligosaccharides, oligosaccharides and xylobiose, etc., as well as some small amounts of xylose and arabinose by cutting off the β-1,4-glycosidic bond. β-Xylosidase and α-L-arabinosidase mainly degrade oligosaccharides into monosaccharides, thereby completely degrading xylan into monosaccharides.
[0004] Xylanases come from a wide range of sources. Animals, plants and microorganisms in nature can all produce xylanases. Microorganisms are the most common source of xylanases. Currently, most studies on the screening of xylanases are based on microorganisms, mainly bacteria and fungi. Studies have shown that xylanases secreted by bacteria are both acidic and alkaline, while xylanases secreted by fungi are only alkaline xylanases. Therefore, strains of xylanases can be screened based on the actual application requirements of xylanases. Currently, the production of xylanases is mainly achieved through fermentation of bacteria and fungi.
[0005] At present, xylanase has been widely used in the pulp and paper industry, and the most widely used is as a bleaching aid in the bleaching section of the pulp and papermaking process. Many studies have found that xylanase pretreatment can improve the bleaching performance of pulp and improve the paper whiteness of bleached pulp. Garg et al. used xylanase from Bacillus stearothermophilus SDX to treat pulp at 60°C and 120 min, and found that the whiteness of the pulp after enzyme treatment increased by 4.75%. In addition, after application by many pulp mills at home and abroad, it was found that adding xylanase before the bleaching section can reduce the bleaching cost of chemical pulp when the required whiteness is achieved, and the bleaching load can be reduced by about 5%~20%.
[0006] However, since the environment of pulp bleaching in the actual production process is mostly a high temperature and alkaline environment, it is difficult for general xylanases to survive in it and it is difficult to play a role. Therefore, it is necessary to develop xylanases with temperature and alkali resistance. The present invention prepares xylanases with temperature and alkali resistance through protein engineering, which can be widely used in the papermaking industry. Summary of the invention
[0007] The purpose of the present invention is to provide a novel alkaline xylanase mutant, which has significantly improved heat resistance and is conducive to its wide application in the field of papermaking.
[0008] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions: The present invention relates to a xylanase mutant comprising an amino acid sequence having at least 90% identity to SEQ ID NO:1 and comprising an amino acid substitution compared to SEQ ID NO:1 at at least one position selected from the group consisting of: 24, 38, 40, 41, 56, 57, 59, 61, 75, 80, 103, 107, 114, 129, 132, 135, 143, 144, 149, 151, 154, 157, 160, 165, 166, 167, 177, 192.
[0009] In some embodiments of the invention, the amino acid sequence of the mutant is at least 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or at least 99% identical to SEQ ID NO:1.
[0010] In some more specific embodiments, the amino acid sequence of the mutant is at least 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, or at least 99.9% identical to SEQ ID NO:1.
[0011] In some embodiments of the invention, the mutant comprises a substitution of at least one amino acid in the following group: Q24P, S38V / K / W / H / T / I, G40M / R / K / F / H, D41P, N56L / I / P / K, A57E / D / Y, A59K / R / I / M / H, H61F / Y, A75S, T80M, T103I, T107E, T114Y, D129L, Q132R / M, D135M, N143D, K144R, T149L, Q151N / Y, C154N, D157E, A160E, N165D, V166I, N167S / W, T177V, D192E.
[0012] The present invention also relates to a DNA molecule encoding the above xylanase mutant.
[0013] The present invention also relates to a recombinant expression vector comprising the above DNA molecule.
[0014] The present invention also relates to a host cell, comprising the above-mentioned recombinant expression vector.
[0015] When the above plasmid is transferred into a host cell, the heat resistance and alkali resistance of the recombinantly expressed xylanase mutant are significantly improved.
[0016] In some embodiments of the present invention, the host cell is Pichia pastoris ( Pichia pastoris ).
[0017] In some embodiments of the present invention, the host cell is Trichoderma reesei ( Trichoderma reesei ).
[0018] The present invention also provides application of the xylanase mutant in the field of papermaking.
[0019] The present invention is based on wild-type xylanase H1 and provides a mutant comprising at least one mutation site among Q24P, S38V / K / W / H / T / I, G40M / R / K / F / H, D41P, N56L / I / P / K, A57E / D / Y, A59K / R / I / M / H, H61F / Y, A75S, T80M, T103I, T107E, T114Y, D129L, Q132R / M, D135M, N143D, K144R, T149L, Q151N / Y, C154N, D157E, A160E, N165D, V166I, N167S / W, T177V, and D192E. Compared with the wild-type xylanase H1, the single-point mutants provided by the present invention generally have a relative enzyme activity of 12.2%-71.4% at 75°C. Among them, the relative enzyme activity of the mutants containing S38T, S38W, D41P, and T177V single points at 75°C is more than 80%, which is much higher than the wild-type xylanase H1, and an unexpected technical effect has been achieved.
[0020] After being treated at pH 9.0-11.0 for 2 h, the residual enzyme activity of wild-type xylanase H1 and its single-point mutants was generally higher than 91%, with almost no enzyme activity loss; After being treated for 2 hours at pH 12.0, the residual enzyme activity rate of the wild-type xylanase H1 was only 45.06%, while the residual enzyme activity rate of the xylanase single-point mutants was as high as 61.51-93.29%, especially the residual enzyme activity rates of the mutants containing single points S38T, S38W, D41P, and T177V were as high as 90.6%, 92.33%, 93.11%, and 93.29%, respectively. This shows that the tolerance of the single-point mutants provided by the present invention to alkaline environments is significantly improved, and unexpected technical effects are achieved.
[0021] In summary, the tolerance of the xylanase mutant provided by the present invention to high temperature and alkaline environment is significantly improved, which is conducive to the wide application of xylanase in the field of papermaking. DETAILED DESCRIPTION
[0022] The present invention discloses a xylanase mutant, a preparation method and application thereof, a DNA molecule encoding the xylanase mutant, a vector, and a host cell. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters to achieve the desired effect. The method and application of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the method and application described herein without departing from the content, spirit and scope of the present invention to achieve and apply the technology of the present invention.
[0023] The present invention has used the conventional techniques and methods used in genetic engineering and molecular biology fields, for example MOLECULAR CLONING: A LABORATORY MANUAL, 3rd Ed. (Sambrook, 2001) and CURRENT PROTOCOLS IN MOLECULAR BIOLOGY (Ausubel, 2003) in the method of recording. These general references provide definitions and methods known to those skilled in the art. But those skilled in the art can, on the basis of the technical scheme recorded in the present invention, adopt other conventional methods, experimental schemes and reagents in this area, and are not limited to the limitation of specific embodiments of the present invention. For example, the present invention can select the following experimental materials and reagents: Strains and vectors: Escherichia coli DH5α, Pichia pastoris GS115, vectors pPIC9k, Amp, and G418 were all purchased from Invitrogen.
[0024] Enzymes and kits: PCR enzyme and ligase were purchased from Takara, restriction endonucleases were purchased from Fermentas, plasmid extraction kit and gel purification recovery kit were purchased from Omega, and GeneMorph II random mutagenesis kit was purchased from Beijing Bomeis Biotechnology Co., Ltd.
[0025] Culture medium formula: Escherichia coli medium (LB medium): 0.5% yeast extract, 1% peptone, 1% NaCl, pH 7.0; Yeast medium (YPD medium): 1% yeast extract, 2% peptone, 2% glucose; Yeast screening medium (MD medium): 2% peptone, 2% agarose; BMGY medium: 2% peptone, 1% yeast extract, 100 mM potassium phosphate buffer (pH 6.0), 1.34% YNB, 4×10 -5 % biotin, 1% glycerol; BMMY medium: 2% peptone, 1% yeast extract, 100 mM potassium phosphate buffer (pH 6.0), 1.34% YNB, 4×10 -5 % biotin, 0.5% methanol; LB-AMP medium: 0.5% yeast extract, 1% peptone, 1% NaCl, 100 μg / mL ampicillin, pH 7.0; LB-AMP plates: 0.5% yeast extract, 1% peptone, 1% NaCl, 1.5% agar, 100 μg / mL ampicillin, pH 7.0; Upper medium: 0.1% MgSO4, 1% KH2PO4, 0.6% (NH4)2SO4, 1% glucose, 18.3% sorbitol, 0.35% agarose; Lower culture medium plate: 2% glucose, 0.5% (NH4)2SO4, 1.5% KH2PO4, 0.06% MgSO4, 0.06% CaCl2, 1.5% agar.
[0026] The present invention will be further described below in conjunction with embodiments: Example 1 Construction of recombinant plasmid From Paecilomyces Paecilomyces. sp The xylanase gene (GeneBank ACS26244.1) of 100 strains of Pichia pastoris was optimized according to the codon preference of Pichia pastoris, and 6 bases GAATTC (EcoRI restriction site) were added before its start codon ATG, and GCGGCCGC (Not I restriction site) was added after its stop codon TAA. The optimized nucleotide sequence was synthesized by Shanghai Jierui Bioengineering Co., Ltd. The xylanase was named H1, its amino acid sequence was SEQ ID NO: 1, and its encoding nucleotide sequence was SEQ ID NO: 2.
[0027] The xylanase gene was digested with restriction enzymes EcoR I and Not I (Fermentas); at the same time, the plasmid pPIC9K was digested with restriction enzymes EcoR I and Not I. The digestion products were purified using a gel purification kit and ligated with T4 DNA ligase (Fermentas). The ligation products were transformed into DH5α Escherichia coli (Invitrogen) and selected with ampicillin. Several clones were sequenced to ensure accuracy.
[0028] The plasmid was purified from the E. coli clone with the correct sequencing results using a plasmid miniprep kit (Omega) to obtain a recombinant plasmid, which was named pPIC9K-H1.
[0029] Example 2 Screening of heat-resistant and alkali-resistant mutants In order to further improve the tolerance of xylanase H1 to high temperature and alkaline conditions, the applicant analyzed its protein structure. The protein is a GH11 family xylanase, and its structure is a β-jelly roll structure. The protein surface and the active center of the protein are exposed to the external environment. Therefore, it is believed that changes in the external environment, especially high temperature or strong acid-base environment, can directly affect the stability of the surface structure of the enzyme and the stability of the active center of the enzyme. Therefore, to improve the tolerance of the enzyme in the environment, it is necessary to increase the rigidity of the protein as a whole and stabilize the overall structure of the enzyme. Under the premise of not destroying the secondary structure and active center of the protein, the gene is further mutated.
[0030] 1.1 Design PCR primers H1-F1, H1-R1: H1-F1: GGC GAATTC ATGATGATTGGTATCACTTCTTTTGC (underlined is the restriction endonuclease EcoRI recognition site); H1-R1: ATA GCGGCCGC TTAACCGACGTCTGCAACGGTAATTC (the underline indicates the recognition site of restriction endonuclease NotI).
[0031] The H1 gene (SEQ ID NO: 1) was used as a template and PCR amplification was performed using the above primers using the GeneMorph II random mutation PCR kit (Bomais). The PCR product was recovered from the gel, digested with EcoRI and NotI, and ligated with the pET21a vector digested with the same enzymes, transformed into Escherichia coli BL21 (DE3), spread on an LB+Amp plate, and cultured inverted at 37°C. After the transformants appeared, they were picked up one by one with a toothpick to a 96-well plate, and 150ul of LB+Amp medium containing 0.1mM IPTG was added to each well. The cells were cultured at 37°C and 220rpm for about 6 h, and the supernatant was discarded after centrifugation. The cells were resuspended in buffer and repeatedly frozen and thawed to break the cell wall to obtain Escherichia coli cell lysate containing xylanase.
[0032] Three lysates were taken out and treated as follows: the first and second lysates were diluted with pH 8.0 buffer, and the third lysate was treated with preheated pH 10.0 0.05M borax-0.2M sodium hydroxide buffer at 37°C for 2h and then diluted with buffer; 30 ul of each of the above treated lysates were placed in three new 96-well plates, and 30 ul of substrate prepared with the corresponding buffer was added to each of the three 96-well plates; the first and third treated lysates were reacted at 50°C for 30 min, and the second treated lysate was reacted at 75°C for 30 min, and the resulting reducing sugar was determined by the DNS method. The enzyme activity levels of different mutants were calculated respectively.
[0033] The experimental results show that different mutants maintain different activities. Some mutations still have high enzyme activity under high temperature reaction conditions and strong alkaline treatment conditions, and some mutations even make its tolerance worse; in addition, some mutations, although they can improve the tolerance of xylanase, their enzymatic properties have changed significantly after mutation, which do not meet the requirements. In the end, the applicant screened and obtained mutation sites that can significantly improve the tolerance of xylanase without significantly affecting its enzyme activity and original enzymatic properties: Q24P, S38V, S38K, S38W, S38H, S38T, S38I, G40M, G40R, G40K, G40F, G40H, D41P, N56L, N56I, N56P, N56K, A57E, A57D, A57Y, A59K, A59R, A59 9I, A59M, A59H, H61F, H61Y, A75S, T80M, T103I, T107E, T114Y, D129L, Q132R, Q132M, D135M, N143 D, K144R, T149L, Q151N, Q151Y, C154N, D157E, A160E, N165D, V166I, N167S, N167W, T177V, D192E.
[0034] Based on the wild-type xylanase H1, the present invention provides mutants respectively containing the above single mutation sites.
[0035] The encoding nucleotide sequences of the xylanase mutants were obtained by referring to the amino acid sequences of the mutants.
[0036] Example 3 Expression of xylanase in Pichia pastoris 3.1 Construction of expression vector The gene sequences of xylanase H1 and its mutants were optimized according to the codon preference of Pichia pastoris and synthesized by Shanghai Jierui Bioengineering Co., Ltd., and two restriction sites, EcoRI and NotI, were added to the 5' and 3' ends of the synthetic sequence, respectively.
[0037] According to the method described in Example 1, the gene sequences of the synthesized xylanase H1 and its mutants were double-digested with EcoRI and NotI, respectively, and then ligated with the pPIC-9K vector that had been digested with the same enzymes at 16°C overnight, and transformed into Escherichia coli DH5a, spread on LB+Amp plates, and inverted cultured at 37°C. After the transformants appeared, colony PCR was performed (reaction system: template-picked single clone, rTaq DNA polymerase 0.5ul, 10×Buffer 2.0μL, dNTPs (2.5mM) 2.0μL, 5'AOX primer (10mM): 0.5μL, 3'AOX primer: 0.5μL, ddH2O 14.5μL, reaction procedure: 95°C pre-denaturation for 5min, 30 cycles: 94°C 30sec, 55°C 30sec, 72°C 2min, 72°C 10min). The positive clones were verified by sequencing and the correct recombinant expression plasmid was obtained.
[0038] 3.2 Construction of Pichia pastoris engineered strains 3.2.1 Preparation of competent yeast The Pichia pastoris GS115 strain was activated on a YPD plate, cultured at 30°C for 48 h, and then the activated GS115 monoclonal was inoculated into 6 mL YPD liquid medium. The culture was incubated at 30°C and 220 rpm for about 12 h, and then the bacterial solution was transferred to a conical flask containing 30 mL YPD liquid medium. The culture was incubated at 30°C and 220 rpm for about 5 h. The bacterial density was detected by a UV spectrophotometer. When the OD600 value was in the range of 1.1–1.3, 4 mL of the bacterial cells were collected into sterile EP tubes by centrifugation at 4°C and 9000 rpm for 2 min, and the supernatant was gently discarded. The remaining supernatant was absorbed with sterile filter paper, and the bacterial cells were resuspended with 1 mL of precooled sterile water, centrifuged at 4°C and 9000 rpm for 2 min, and the supernatant was gently discarded. After repeated washing with 1 mL of sterile water, the cells were centrifuged at 4°C and 9000 rpm for 2 min, and the supernatant was gently discarded. The cells were then washed with 1 mL of sterile water, centrifuged at 4°C and 9000 rpm for 2 min, and the supernatant was gently discarded. The cells were then washed with 1 mL of precooled sorbitol (1 mol / L); centrifuge at 4°C, 9000 rpm for 2 min, gently discard the supernatant, and gently resuspend the cells in 100-150 μl pre-cooled sorbitol (1 mol / L).
[0039] 3.2.2 Transformation and screening The recombinant expression plasmids constructed in 3.1 were linearized with Sac I, and the linearized fragments were purified and recovered and transformed into Pichia pastoris GS115 by electroporation. The recombinant Pichia pastoris strains were screened on MD plates, and then multi-copy transformants were screened on YPD plates containing different concentrations of geneticin (0.5 mg / mL-8 mg / mL).
[0040] The obtained transformants were transferred to BMGY medium and cultured at 30°C and 250 rpm for 1 day; then transferred to BMMY medium and cultured at 30°C and 250 rpm; 0.5% methanol was added every day to induce expression for 4 days; the bacteria were removed by centrifugation at 9000 rpm for 10 minutes to obtain the fermentation supernatant containing xylanase H1 and xylanase mutants, respectively.
[0041] (1) Definition of xylanase activity unit Under the conditions of temperature of 50°C and pH of 8.0, the amount of enzyme required to degrade and release 1 μmol of reducing sugar from a 5 mg / ml xylan solution per minute is one enzyme activity unit, expressed as U.
[0042] (2) Xylanase activity determination method Pipette 10.0 ml of xylan solution and equilibrate at 50℃ for 20 min.
[0043] Pipette 10.0 ml of appropriately diluted enzyme solution and equilibrate at 50℃ for 5 min.
[0044] Blank sample determination: Pipette 2.00 ml of appropriately diluted enzyme solution (already balanced at 50°C), add it to a graduated test tube, then add 5 ml of DNS reagent, and electromagnetically oscillate for 3 s. Then add 2.0 ml of xylan solution, equilibrate at 50°C for 30 min, and heat in a boiling water bath for 5 min. Cool to room temperature with tap water, add water to make up to 25 ml, and electromagnetically oscillate for 3 s to 5 s. Use the standard blank sample as a blank control and measure the absorbance A at 540 nm. B .
[0045] Sample determination: Pipette 2.00 ml of appropriately diluted enzyme solution (equilibrated at 50°C) and add it to a graduated test tube, then add 2.0 ml of xylan solution (equilibrated at 50°C), electromagnetically oscillate for 3 s, and keep the temperature at 50°C for 30 min. Add 5.0 ml of DNS reagent and electromagnetically oscillate for 3 s to terminate the enzymatic reaction. Heat in a boiling water bath for 5 min, cool to room temperature with tap water, add water to make up to 25 ml, and electromagnetically oscillate for 3 s. Use the standard blank sample as the blank control and measure the absorbance A at 540 nm. E .
[0046]
[0047] Where: X D —Activity of xylanase in the sample dilution, U / ml; A E —Absorbance of enzyme reaction solution; A B—Absorbance of enzyme blank sample; K—slope of the standard curve; C O —intercept of the standard curve; M—molar mass of xylose M(C5XYN110O5) = 150.2 g / mol; t—enzymatic reaction time, min; 1000—conversion factor, 1 mmol = 1000 μmol; X D The value should be between 0.04 and 0.10 U / ml. If it is not within this range, the dilution of the enzyme solution should be reselected and the analysis should be repeated.
[0048] X = X D ·D f (2) X—activity of xylanase in the sample, U / ml; Df—dilution factor of the sample.
[0049] (3) Measurement results The enzyme activity was detected according to the above method, and the results showed that the enzyme activity of the fermentation supernatant of the Pichia pastoris recombinant strain expressing xylanase H1 and its mutants constructed above was 310-550 U / mL.
[0050] Example 4 Expression of xylanase in Trichoderma reesei First, according to the codon preference of Trichoderma, the gene sequences of xylanase H1 and its mutants were optimized. The optimized gene sequences were synthesized by Shanghai Jierui Bioengineering Co., Ltd., and two restriction sites, KpnI and MluI, were added at the 5' and 3' ends of the synthetic sequence.
[0051] 4.1 Construction of expression vector The synthesized xylanase gene fragment and pSC1G vector were digested with restriction endonucleases KpnI and MluI (Fermentas), respectively, and the digestion products were purified using a gel purification kit, and the above xylanase gene and pSC1G vector digestion products were ligated with T4 DNA ligase (Fermentas) and transformed into Escherichia coli Trans5α (Transgen), selected with ampicillin, and the clones were sequenced (Invitrogen) for verification. After sequencing was correct, a recombinant plasmid containing the xylanase gene was obtained.
[0052] 4.2 Construction of recombinant strains of Trichoderma reesei (1) Protoplast preparation Take the host fungus Trichoderma reesei ( Trichoderma reesei)UE spore suspension was inoculated on PDA plates and cultured at 30℃ for 6 days. After the spores were abundant, colonies of about 1cm×1cm were cut and placed in liquid culture medium containing 120 mL YEG+U (0.5% yeast powder, 1% glucose, 0.1% uridine) and cultured at 30℃ with shaking at 220 rpm for 14-16 h. Collect the mycelium by filtering with sterile gauze and wash it once with sterile water; place the mycelium in a conical flask containing 20 mL of 10 mg / mL lysing enzyme solution (Sigma L1412) at 30°C and 90 rpm for 1-2 h; observe the progress of protoplast transformation under a microscope; Add 20 mL of pre-cooled 1.2 M sorbitol (1.2 M sorbitol, 50 mM Tris-Cl, 50 mM CaCl2) to the above-mentioned conical flask, shake gently, collect the filtrate through sterile Miracloth filter cloth, centrifuge at 3000 rpm, 4℃ for 10 min; discard the supernatant, add 5 mL of pre-cooled 1.2 M sorbitol solution to suspend the cells, centrifuge at 3000 rpm, 4℃ for 10 min; discard the supernatant, add appropriate amount of pre-cooled 1.2 M sorbitol to suspend and package (200 μL / tube, protoplast concentration is 10 8 / mL).
[0053] (2) Expression vector transformation The following operations were all performed on ice. 10 μg of the recombinant plasmid constructed above was added to a 7 mL sterile centrifuge tube containing 200 μL of protoplast solution, and then 50 μL of 25% PEG (25% PEG, 50 mM Tris-Cl, 50 mM CaCl2) was added. The tube bottom was flicked to mix and placed on ice for 20 min. 2 mL of 25% PEG was added, mixed and placed at room temperature for 5 min. 4 mL of 1.2 M sorbitol was added, mixed gently and poured into the upper culture medium melted and maintained at 55°C. After mixing gently, the culture medium was spread on the prepared lower culture medium plate and cultured at 30°C for 5-7 d until transformants grew. The grown transformants were picked to the lower culture medium plate for rescreening. The strains with smoother colony edge morphology were positive transformants.
[0054] According to the above method, the applicant constructed and obtained engineered strains of Trichoderma reesei that recombinantly expressed xylanase H1 and its mutants.
[0055] (3) Fermentation verification and enzyme activity determination The engineered strains of Trichoderma reesei obtained by the above construction were inoculated on PDA solid plates, inverted and cultured in a constant temperature incubator at 30°C for 6-7 days, and after the spores were abundant, two mycelium blocks with a diameter of 1 cm were taken and inoculated in 250 mL triangular flasks containing 50 mL fermentation medium (1.5% glucose, 1.7% lactose, 2.5% corn steep liquor, 0.44% (NH4)2SO4, 0.09% MgSO4, 2% KH2PO4, 0.04% CaCl2, 0.018% Tween-80, 0.018% trace elements), and cultured at 30°C for 48 hours, and then at 25°C for 48 hours. The fermentation broth was centrifuged to obtain fermentation supernatants containing xylanase H1 and its mutants.
[0056] Enzyme activity was detected according to the above method, and the results showed that the enzyme activity of the fermentation supernatant of the recombinant strain of Trichoderma reesei expressing xylanase H1 and its mutants constructed above was 300-500 U / mL.
[0057] Example 5 Analysis of the heat resistance of xylanase mutants The fermentation supernatant of the above recombinant strain was diluted 10 times with 0.1M disodium hydrogen phosphate-0.05M citric acid buffer, and the diluted xylanase activity was measured at 50°C and 75°C respectively. The relative enzyme activity at 75°C was calculated with the enzyme activity of the fermentation supernatant at 50°C as 100%. The specific results are shown in Table 1.
[0058] Relative enzyme activity (%) = sample enzyme activity at 75°C / sample enzyme activity at 50°C × 100%.
[0059] Table 1 Relative enzyme activities of xylanase H1 and its mutants at 75℃ Xylanases and their single-point mutants 75℃ / 50℃ relative enzyme activity (%) Wild-type H1 49% Q24P 56% S38T 84% N56I 68% G40M 56% G40R 58% G40K 55% G40F 59% G40H 60% S38V 69% S38K 68% S38W 82% S38H 68% S38T 62% S38I 69% D41P 84% N56L 59% N56I 68% N56P 59% N56K 60% A57E 61% A57D 59% A57 68% A59K 64% A59R 62% A59I 72% A59M 71% A59H 59% H61F 56% H61Y 67% A75S 67% T80M 65% T103I 57% T107E 67% T114Y 58% Q132M 59% Q132R 55% D135M 72% N143D 64% K144R 60% T149L 55% Q151N 62% Q151Y 69% C154N 56% D157E 56% A160E 68% N165D 64% N167S 58% N167W 58% T177V 81% From the data in Table 1, it can be seen that compared with the wild-type xylanase H1, the relative enzyme activity of the single point mutants provided by the present invention at 75°C is generally increased by 12.2%-71.4%. Among them, the relative enzyme activity of the mutants containing S38T, S38W, D41P, and T177V single points at 75°C is more than 80%, which is much higher than the wild-type xylanase H1. This shows that the heat resistance of the single point mutants provided by the present invention is significantly improved, and an unexpected technical effect has been achieved.
[0060] Example 6 Analysis of tolerance of xylanase mutants to alkaline environment Dilute the fermentation supernatant of the above recombinant strain to 50U / ml with deionized water; take 1ml of the supernatant and add it to 9ml of the corresponding pH (pH9.0, 10.0, 11.0, 12.0) buffer that has been preheated for 10min, and treat at 37℃ for 2h; add 5ml of supplementary solution quickly after the reaction is completed, shake well; then dilute with buffer and determine the residual enzyme activity. The enzyme activity of the untreated fermentation supernatant is 100%, and the residual enzyme activity rate is calculated.
[0061] Residual enzyme activity (%) = enzyme activity of treated samples / enzyme activity of untreated samples × 100%.
[0062] The results showed that after being treated at pH 9.0-11.0 for 2 hours, the residual enzyme activity of wild-type xylanase H1 and its single-point mutants was generally higher than 91%, with almost no enzyme activity loss. After being treated for 2 hours at pH 12.0, the residual enzyme activity rate of the wild-type xylanase H1 was only 45.06%, while the residual enzyme activity rate of the xylanase single-point mutants was as high as 61.51-93.29%, especially the residual enzyme activity rates of the mutants containing single points S38T, S38W, D41P, and T177V were as high as 90.6%, 92.33%, 93.11%, and 93.29%, respectively. This shows that the tolerance of the single-point mutants provided by the present invention to alkaline environments is significantly improved, and unexpected technical effects are achieved.
[0063] In summary, the mutation sites screened by the present invention are Q24P, S38V, S38K, S38W, S38H, S38T, S38I, G40M, G40R, G40K, G40F, G40H, D41P, N56L, N56I, N56P, N56K, A57E, A57D, A57Y, A59K, A59R, A59I, A59M, A59H, H61F, H61Y, A75S, T80M, T10 3I, T107E, T114Y, D129L, Q132R, Q132M, D135M, N143D, K144R, T149L, Q151N, Q151Y, C154N, D157E, A160E, N165D, V166I, N167S, N167W, T177V, and D192E can significantly improve the tolerance of xylanase H1 in high temperature and alkaline environments, thus facilitating its widespread application in the papermaking industry.
Claims
1. A xylanase mutant, characterized in that The mutant is a xylanase with an amino acid sequence of SEQ ID NO: 1, in which the 177th amino acid is changed from Thr to Val.
2. A DNA molecule encoding the xylanase mutant according to claim 1.
3. A recombinant expression plasmid comprising the DNA molecule of claim 2.
4. A host cell, characterized in that The host cell comprises the recombinant expression plasmid according to claim 3.
5. The host cell according to claim 4, characterized in that The host cell is Pichia pastoris ( Pichia pastoris ).
6. The host cell according to claim 5, characterized in that The host cell is Trichoderma reesei ( Trichoderma reesei ).
7. Use of the xylanase mutant according to claim 1 in the field of papermaking.
Citation Information
Patent Citations
Alkaline xylanase mutant and application thereof
CN104450650A
Alkaline xylanase mutant and application thereof
CN104845955A
Recombinant basic xylanase resistant to chelating agent ethylenediamine tetraacetic acid and construction method thereof
CN104928270A
Mutated Xylanase Gene with a Broad PH Range of Reaction and Site-Specific Mutagenesis Method Thereof
US20080254526A1
Cited By
Alkaline xylanase mutant and application thereof
CN120624414A
